Metraipolis › archive › dc_f655074247fe

FDA-approved PDE4 inhibitors alleviate the dominant toxicity of ALS-FTD-associated CHCHD10S59L in Drosophila and human cells — Europe PMC PMID:41732281

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41732281
DOI
10.1016/j.isci.2026.114879
License (as archived)
solo-consultazione
Archived
2026-11-06T07:04:11.611Z
SHA-256 of the archived text
b73b04367c70b78c72806e2e454b39c45c1179af1942a88628cfa3f2d3716a4f
Stable URL of this page
https://metraipolis.com/documento/dc_f655074247fe

How to cite

FDA-approved PDE4 inhibitors alleviate the dominant toxicity of ALS-FTD-associated CHCHD10S59L in Drosophila and human cells — Europe PMC PMID:41732281 — Europe PMC (en), https://europepmc.org/article/MED/41732281 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f655074247fe (Metraipolis archive dc_f655074247fe, sha256 b73b04367c70b78c72806e2e454b39c45c1179af1942a88628cfa3f2d3716a4f)
BibTeX
@misc{dcf655074247fe,
  title = {FDA-approved PDE4 inhibitors alleviate the dominant toxicity of ALS-FTD-associated CHCHD10S59L in Drosophila and human cells — Europe PMC PMID:41732281},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41732281},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f655074247fe; sha256 b73b04367c70b78c72806e2e454b39c45c1179af1942a88628cfa3f2d3716a4f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41732281. Agents can read the archived copy with the MCP tool read_document.